ANNOVIS BIO (ANVS) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to ANNOVIS BIO (ANVS) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of ANVS during the latest reporting period was Renaissance Technologies LLC, which increased its reported ANVS position by approximately $726,534 based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in ANVS exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward ANNOVIS BIO (ANVS). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $734,452.68 in reported ANVS exposure during the latest filing period, reflecting continued institutional interest in ANNOVIS BIO's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy325,800347,600$775,148
Q1 2025Renaissance Technologies LLCBuy5,10021,800$32,700
Q1 2022Renaissance Technologies LLCBuy12,69723,197$310
Q3 2020Renaissance Technologies LLCBuy20,61520,615$99

Frequently asked questions about ANVS activity

  • Which institutional owners are buying ANVS?

    Institutional owners buying ANVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ANVS activity?

    "Buy" means an investor increased their reported position in ANVS compared to the prior reporting period. This reflects growing exposure to ANNOVIS BIO (ANVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ANVS increasing?

    Institutional interest in ANVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.